FFM
MRTX

Fairmount Funds Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Fairmount Funds Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-67,800
Closed -$11.6M – 21
2021
Q1 		$11.6M Buy
67,800
+7,300
+12% +$1.25M 4.9% 10
2020
Q4 		$13.3M Buy
60,500
+25,500
+73% +$5.6M 4.75% 11
2020
Q3 		$5.81M Buy
+35,000
New +$5.81M 2.46% 14